US Pharma MarketingThe U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
Source: MedTech Dive